Connect with us
[bsa_pro_ad_space id=12]

Business

US lawmakers accuse Pfizer, Eli Lilly of testing new drugs on prisoners in Communist China

Published

6 minute read

From LifeSiteNews

By Calvin Freiburger

Two Republicans and two Democrats in the House of Representatives have leveled stunning allegations against two pharmaceutical companies, calling on the U.S. Food and Drug Administration to investigate potential testing of drugs on prisoners of Communist China.

A bipartisan group of Congress members has leveled stunning allegations against pharmaceutical companies Pfizer and Eli Lilly, calling on the U.S. Food & Drug Administration (FDA) to investigate the potential testing of new drugs on prisoners of Communist China.

The letter was sent August 19 to FDA Commissioner Dr. Robert Calf and signed by Select Committee on the Chinese Communist Party (CCP) Chair Rep. John Moolenaar, a Republican from Florida and ranking member and Illinois Democratic Rep. Raja Krishnamoorthi, Health Energy & Commerce Subcommittee ranking member and California Democratic Rep. Anna Eshoo, and Florida Republican Rep. Neal Dunn.

“For over a decade, it appears that U.S. biopharmaceutical companies conducted clinical trials with China’s military organizations, and specifically with medical centers and hospitals affiliated with the People’s Liberation Army’s (PLA), to determine the safety and effectiveness of new drug candidates prior to approval,” the letter reads. “ … we are also concerned that U.S. biopharmaceutical companies have conducted clinical trials with hospital infrastructure located in the Xinjiang Uyghur Autonomous Region (XUAR), where the Chinese Communist Party (CCP) is engaged in genocide of the Uyghur population.”

The lawmakers’ review of publicly available data found that over the last decade major American Pharma companies have conducted “hundreds of clinical trials in China that included at least one entity with PLA in the name as a research trial partner.”

“Even today, one major U.S. biopharmaceutical entity is actively recruiting patients for an advanced Alzheimer drug trial and is partnered with the PLA’s General Hospital and Medical School … and the PLA’s Air Force Medical University. … Previously, another U.S. biopharmaceutical entity used the 307 Hospital of the PLA (307 医院) as the setting for a cancer therapeutic clinical trial.”

Such work not only carries risks of sensitive technology falling into the CCP’s hands, “there are also U.S. biopharmaceutical trials listed on clinicaltrials.gov that were conducted with hospitals located in the XUAR, where credible investigative reports have shown that ethnic minorities in the region are repeatedly forced by the CCP to surrender their body autonomy. As we know, there is simply no ability for firms to conduct due diligence to ensure that clinical trials done in XUAR are voluntary.”

Axios noted that the trials in question concern Pfizer’s kidney cancer drug axitinib (brand name Inlyta), and Eli Lilly’s Alzheimer’s drug donanemab (brand name Kisunla).

The lawmakers asked the FDA to answer several questions related to its knowledge and oversight of such trials and called on the agency to “take on a greater role in protecting U.S. national security interests. With this data, it is clear that the FDA should play a greater role in analyzing U.S. biopharma entities (sic) clinical trial operations in the PRC.”

Pfizer responded that it “is committed to conducting business in an ethical and responsible manner. This includes respecting internationally recognized human rights throughout our operations,” Straight News reported. Eli Lilly claimed that it is “committed to IP protections, and we conduct robust assessments of our partners to ensure they meet Lilly standards for research and data privacy. Further, we oversee their activities when conducting clinical trials to ensure quality and data integrity.”

large body of evidence has found that mass restrictions on personal and economic activity undertaken in 2020 and part of 2021 caused far more harm than good in terms of personal freedom and economics as well as public health, particularly through the controversial COVID vaccines rushed through development by Pfizer, Moderna, Johnson & Johnson, and the Trump administration.

Yet, so far Big Pharma has largely escaped accountability thanks to the federal Public Readiness and Emergency Preparedness (PREP) Act of 2005. According to the Congressional Research Service (CRS), the PREP Act empowers the federal government to “limit legal liability for losses relating to the administration of medical countermeasures such as diagnostics, treatments, and vaccines.” Near the beginning of the 2020 COVID-19 outbreak, the Trump administration invoked the Act in declaring the virus a “public health emergency.”

Under this “sweeping” immunity, CRS explained, the federal government, state governments, “manufacturers and distributors of covered countermeasures,” and licensed or otherwise-authorized health professionals distributing those countermeasures are shielded from “all claims of loss” stemming from those countermeasures, with the exception of “death or serious physical injury” brought about through “willful misconduct,” a standard that, among other hurdles, requires the offender to have acted “intentionally to achieve a wrongful purpose.”

A handful of states are currently making efforts to hold Pharma companies accountable despite this hurdle, such as Florida’s ongoing grand jury investigation into the vaccines’ manufacturers, and a Kansas lawsuit accusing Pfizer of misrepresentation for calling the shots “safe and effective.”

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

Losses Could Reach Nearly One Billion: When Genius Failed…..Again

Published on

Illustration by Daniel Medina

By Eric Salzman

The smartest guys in the room fall for the same scam twice in less than 5 years

THE SCHEME: Fraud and Money Laundering

THE COMPANY: Stenn Technologies

Racket News is a reader-supported publication.

To receive new posts and support my work, consider becoming a free or paid subscriber.

THE NEWS: For the second time in five years, a scam involving sexing up a boring, centuries old financing business blew up in the faces of some of the world’s largest banks

You know the old saying. Fool me once, shame on you. Fool me twice…

In December, “fintech” supply chain financier Stenn Technologies and its subsidiaries Stenn Assets UK Ltd and Stenn International Ltd, collapsed, spanking investors and lenders such as Citigroup, Nexis, BNP Paribas, HSBC and private equity firm Centerbridge. Just a month prior to the blow-up, Stenn was viewed as a fintech unicorn with a robust $1 billion book of business, poised for strong growth.

As we’ve seen time and again, a unicorn can quickly die when a company’s business model screams fraud to anyone bothering to look.

Stenn Technologies claimed to use artificial intelligence and state of the art technology to analyze credit and money laundering risk in order to turn a low margin, supply chain financing business into an awesome, high return, low risk securitized product.

Here’s a quick explanation of supply chain financing:

1. A company delivers its product to a buyer and the buyer promises to pay in a few months’ time, creating an accounts receivable.

2. The company that has the accounts receivable sends it to the supply chain financier (Greensill Capital or Stenn Technologies).

3. The supply chain financier pays the company cash for the receivable minus a discount which is another business practice called factoring.

4. The buyer pays the financier the full amount of the receivable on the due date.

Supply chain financing is nothing new. It was probably around when Marco Polo set out for the Orient.

If it sounds boring, that’s because it is, or at least is supposed to be. Lex Greensill’s Greensill Capital changed that a decade ago.

Through fancy structuring, as well as four private jets, Greensill created a byzantine circular loop where money flowed around the world, much of it to Greensill favorites like steel maker Sanjeev Gupta and then back again. The operation was continuously funded by either GAM, Credit Suisse, SoftBank as well as Greensill’s own German bank, Greensill Bank AG. After a while, as more money poured into Greensill from eager investors, the company began to essentially just lend money out, mostly to Gupta while calling the transactions “future receivables.”

Greensill Capital collapsed under the weight of fraud in 2021, costing its big investors mentioned above billions. Matt reported on the story here in 2021.

Greensill’s receivable notes (the fancy structuring) were insured by a number of insurers, the biggest being Japanese insurer Tokio Marine. The insurance made investors comfortable because, if Tokio Marine insured it, the notes have to be money good, right?

Wrong.

At one point, Tokio had nearly $8 billion of exposure to Greensill deals. How insurers got comfortable with insuring receivables to a blizzard of shell companies that all seemed to point back to Gupta and Lex’s pockets is anyone’s guess, but when Tokio finally did a good look under the hood, they cried insurance fraud and Greensill came crashing down. Credit Suisse investors alone lost $10 billion.

At this point, we need to hear from Lt. Commander Montgomery Scott, better known as Scotty.

So now, we’re at the shame on you portion of the story.

Astoundingly, Stenn Technologies was able to pull off a similar scam just a couple of years later, posing as a fintech company, supposedly using the latest in technology to do global supply chain financing faster and better than everyone else in the business.

The victims are new, but given the high publicity of Greensill’s failure, you’d figure they would catch on.

According to Bloomberg News, “Stenn’s main backers were Citigroup Inc., BNP Paribas SA, Natixis and HSBC Holdings Plc while Barclays Plc, M&G Plc and Goldman Sachs Group also backed the transaction.”

Private equity firm Centerbridge invested $50 million in capital and valued the company at $900 million in 2022.

In 2022, TechCrunch described the secret sauce that Stenn was supposedly using to bring a 13th century business into the modern age.

Stenn — which applies big data analytics, taking a few datapoints about a business (the main two being what money it has coming in and going out based on invoices) and matching them up against an algorithm that takes some 1,000 other factors into account to determine its eligibility for a loan of up to $10 million; and on the other side taps a network of institutions and other big lenders to provide the capital for that financing.

Perhaps this multi-factor algorithm was super cool when they showed it to investors and lending partners. The only problem was Stenn, in the words of a business crime attorney who spoke to Bloomberg, “has all the hallmarks of both fraud and money laundering.”

Greensill might have been a bit hard to figure out with large, respected insurance companies insuring their notes.

But anyone who took the time to investigate Stenn Technologies by simply looking at the data they pumped out to investors weekly would have seen the scheme for what it was.

While it appears the previously mentioned institutional investors didn’t bother to investigate, Bloomberg did and the results were darkly hilarious.

Some of Stenn’s biggest suppliers were tiny companies in Thailand and Hong Kong with little in common yet corporate filings for all of them list the same Russian name as a backer. One in Singapore was accused by the U.S. of enabling payments to Russian naval intelligence and sanctioned in August. Tracing a group owned by another Russian investor that was supposedly shipping millions of dollars of goods to corporations in Switzerland and Canada led to a derelict Prague building with boarded-up windows.

Bloomberg contacted the largest 50 firms that were supposedly the buyers for what Stenn’s suppliers produced, and the bulk had no idea who Stenn Technologies or these suppliers were! A spokesman for Edion Corp., one of the biggest electronics retailers in Japan, told Bloomberg, “we have absolutely no knowledge of this matter. We really have no idea what it’s about.”

Essentially, the data produced by Stenn highlighted thousands of bogus transactions on a weekly basis to investors, lying about who was paying and who was receiving billions of dollars of funds. According to Bloomberg, investors received these details with the name of the suppliers and buyers included. Therefore, at any time, investors could have done a sanity check on these obscure suppliers to see who they were, or in this case, weren’t.

HSBC finally caught up to what Stenn was doing. Again from the Bloomberg report:

HSBC triggered Stenn’s downfall when it lodged an application to the UK courts, alleging that its officials had uncovered ‘deeply troubling issues on a large scale.’ The
invoices at the heart of the deal weren’t ‘genuine debts’ and payments to suppliers weren’t coming from ‘blue-chip companies’ but from bogus firms with similar names, according to the complaint filed by the London-based bank.

Investors are facing a potential loss of $200 million, although it could be a lot more as $978 million in invoiced-financed notes are outstanding, Bloomberg reports.

There is a bright side to Stenn’s collapse though. A senior trade finance official told The Sunday Times:

“The saving grace here is at least it’s smaller than Greensill.”

Well played.

Racket News is a reader-supported publication.

To receive new posts and support my work, consider becoming a free or paid subscriber.

Continue Reading

Banks

TD Bank Account Closures Expose Chinese Hybrid Warfare Threat

Published on

From the Frontier Centre for Public Policy

By Scott McGregor

Scott McGregor warns that Chinese hybrid warfare is no longer hypothetical—it’s unfolding in Canada now. TD Bank’s closure of CCP-linked accounts highlights the rising infiltration of financial interests. From cyberattacks to guanxi-driven influence, Canada’s institutions face a systemic threat. As banks sound the alarm, Ottawa dithers. McGregor calls for urgent, whole-of-society action before foreign interference further erodes our sovereignty.

Chinese hybrid warfare isn’t coming. It’s here. And Canada’s response has been dangerously complacent

The recent revelation by The Globe and Mail that TD Bank has closed accounts linked to pro-China groups—including those associated with former Liberal MP Han Dong—should not be dismissed as routine risk management. Rather, it is a visible sign of a much deeper and more insidious campaign: a hybrid war being waged by the Chinese Communist Party (CCP) across Canada’s political, economic and digital spheres.

TD Bank’s move—reportedly driven by “reputational risk” and concerns over foreign interference—marks a rare, public signal from the private sector. Politically exposed persons (PEPs), a term used in banking and intelligence circles to denote individuals vulnerable to corruption or manipulation, were reportedly among those flagged. When a leading Canadian bank takes action while the government remains hesitant, it suggests the threat is no longer theoretical. It is here.

Hybrid warfare refers to the use of non-military tools—such as cyberattacks, financial manipulation, political influence and disinformation—to erode a nation’s sovereignty and resilience from within. In The Mosaic Effect: How the Chinese Communist Party Started a Hybrid War in America’s Backyard, co-authored with Ina Mitchell, we detailed how the CCP has developed a complex and opaque architecture of influence within Canadian institutions. What we’re seeing now is the slow unravelling of that system, one bank record at a time.

Financial manipulation is a key component of this strategy. CCP-linked actors often use opaque payment systems—such as WeChat Pay, UnionPay or cryptocurrency—to move money outside traditional compliance structures. These platforms facilitate the unchecked flow of funds into Canadian sectors like real estate, academia and infrastructure, many of which are tied to national security and economic competitiveness.

Layered into this is China’s corporate-social credit system. While framed as a financial scoring tool, it also functions as a mechanism of political control, compelling Chinese firms and individuals—even abroad—to align with party objectives. In this context, there is no such thing as a genuinely independent Chinese company.

Complementing these structural tools is guanxi—a Chinese system of interpersonal networks and mutual obligations. Though rooted in trust, guanxi can be repurposed to quietly influence decision-makers, bypass oversight and secure insider deals. In the wrong hands, it becomes an informal channel of foreign control.

Meanwhile, Canada continues to face escalating cyberattacks linked to the Chinese state. These operations have targeted government agencies and private firms, stealing sensitive data, compromising infrastructure and undermining public confidence. These are not isolated intrusions—they are part of a broader effort to weaken Canada’s digital, economic and democratic institutions.

The TD Bank decision should be seen as a bellwether. Financial institutions are increasingly on the front lines of this undeclared conflict. Their actions raise an urgent question: if private-sector actors recognize the risk, why hasn’t the federal government acted more decisively?

The issue of Chinese interference has made headlines in recent years, from allegations of election meddling to intimidation of diaspora communities. TD’s decision adds a new financial layer to this growing concern.

Canada cannot afford to respond with fragmented, reactive policies. What’s needed is a whole-of-society response: new legislation to address foreign interference, strengthened compliance frameworks in finance and technology, and a clear-eyed recognition that hybrid warfare is already being waged on Canadian soil.

The CCP’s strategy is long-term, multidimensional and calculated. It blends political leverage, economic subversion, transnational organized crime and cyber operations. Canada must respond with equal sophistication, coordination and resolve.

The mosaic of influence isn’t forming. It’s already here. Recognizing the full picture is no longer optional. Canadians must demand transparency, accountability and action before more of our institutions fall under foreign control.

Scott McGregor is a defence and intelligence veteran, co-author of The Mosaic Effect: How the Chinese Communist Party Started a Hybrid War in America’s Backyard, and the managing partner of Close Hold Intelligence Consulting Ltd. He is a senior security adviser to the Council on Countering Hybrid Warfare and a former intelligence adviser to the RCMP and the B.C. Attorney General. He writes for the Frontier Centre for Public Policy.

Continue Reading

Trending

X